Orchard Therapeutics PLC Sponsored ADR EBITDA 2019-2023 | ORTX
Orchard Therapeutics PLC Sponsored ADR ebitda from 2019 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Orchard Therapeutics PLC Sponsored ADR Annual EBITDA (Millions of US $) |
|
|---|---|
| 2022 | $-125 |
| 2021 | $-138 |
| 2020 | $-157 |
| 2019 | $-176 |
| 2018 | $-240 |
| 2017 | $-38 |
| 2016 | $-19 |
| Orchard Therapeutics PLC Sponsored ADR Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2023-09-30 | $-25 |
| 2023-06-30 | $-23 |
| 2023-03-31 | $-26 |
| 2022-12-31 | $-31 |
| 2022-09-30 | $-25 |
| 2022-06-30 | $-32 |
| 2022-03-31 | $-37 |
| 2021-12-31 | $-36 |
| 2021-09-30 | $-32 |
| 2021-06-30 | $-35 |
| 2021-03-31 | $-35 |
| 2020-12-31 | $-39 |
| 2020-09-30 | $-26 |
| 2020-06-30 | $-46 |
| 2020-03-31 | $-46 |
| 2019-12-31 | $-50 |
| 2019-09-30 | $-42 |
| 2019-06-30 | $-55 |
| 2019-03-31 | $-29 |
| 2018-12-31 | $-30 |
| 2018-09-30 | $-37 |
| 2018-06-30 | $-159 |
| 2018-03-31 | $-14 |
